The world is fighting a war against a virus and Singapore scientists are pulling their weight when it comes to building up an arsenal of knowledge that can be used to vanquish the enemy.
But their expertise did not spring up overnight. It is the fruit of the continuing investment in the health and biomedical sciences that Singapore started decades ago - an investment that, during this crisis, is paying off handsomely.
For instance, in the early stages of the coronavirus outbreak, scientists here developed a diagnostic test that allowed clinicians to identify and quickly isolate infected patients.
Since then, a multitude of inventions and discoveries have been rolled out.
Disinfection robots, armed with ultraviolet ray "swords", will soon rove some public places to get rid of viruses lingering on surfaces.
Swabbing booths have also been designed to provide extra protection for healthcare workers doing large-scale Covid-19 tests.
But as Mr Frederick Chew, chief executive of the Agency for Science, Technology and Research (A*Star), points out, these products do not just appear overnight. They are founded on a strong capability base built up and nurtured painstakingly over time, he tells Insight.
"In terms of peacetime dividends, Singapore is starting to reap tangible health and economic outcomes from investments made into the health and biomedical sciences," he says.
"In this Covid-19 wartime period, the same peacetime capability sets are being strung together to swiftly address Singapore's public health emergency needs."
Today, Singapore's biomedical manufacturing cluster makes up more than 4 per cent of the nation's gross domestic product and employs more than 24,000 people, many of whom are in high-skilled jobs.
It also supports the development of healthcare solutions and products that benefit Singaporeans, given the focus of research on diseases prevalent among Asian populations, says a spokesman for Singapore's National Research Foundation (NRF).
Many of the scientists have been working behind the scenes for years. But it was perhaps not until the Covid-19 crisis that the importance of their work has been highlighted.
Singapore has been building up the nation's capabilities in the health and biomedical sciences over the past two decades, notes the NRF spokesman.
This started with the formation of A*Star and its Biomedical Research Council research institutes, which preceded the outbreak of the severe acute respiratory syndrome (Sars) in 2003. A*Star was formed in 2002, taking over from what was known as the National Science and Technology Board.
It was this long-term investment that allowed the country to respond quickly and effectively to the Covid-19 outbreak, adds the NRF spokesman.
For example, NRF supported scientists such as Professor Wang Linfa of the Duke-NUS Medical School to pursue basic research on bat-borne viruses, which include coronaviruses. This allowed Prof Wang and his team to achieve significant breakthroughs in Covid-19 when called upon.
Preliminary research has indicated that the coronavirus-causing Covid-19 originated in bats.
It took Prof Wang's team just one week to successfully culture the virus from an infected person's sample after Singapore reported its first case on Jan 23, making it the third country in the world outside China to do so.
The ability to grow the virus in a laboratory during the early stages of the outbreak was a crucial starting point for scientists here, in terms of helping them develop new diagnostic methods or a potential vaccine, for instance.
The Sars outbreak had also spurred action, prompting an emphasis on infectious diseases as a focus area, says the NRF spokesman. This led to the formation of the National Centre for Infectious Diseases (NCID), which developed state-of-the-art facilities and created a national focal point for work around infectious diseases, she adds.
The experience with infectious diseases over the years, including Sars and the swine and avian influenza, also helped to hone the radars of researchers here.
The moment a series of pneumonia-like cases was reported in Wuhan, China, last December, scientists and clinicians at A*Star and Tan Tock Seng Hospital were already on high alert.
After China shared the genome sequence of the coronavirus in the second week of January, they - scientists and doctors - worked together to develop and roll out a diagnostic test kit in less than a month. This was a record, considering that a similar one for Sars had taken months.
Today, the Fortitude Kit has been deployed in 13 public and private hospitals and laboratories in Singapore, as well as in more than 20 other places, including Hong Kong, New Zealand and the United States, says A*Star.
Microbiologist Julien Lescar, an associate professor at Nanyang Technological University's School of Biological Sciences, came to Singapore from France in 2002, just before the outbreak of Sars.
And since then, the scientific landscape in Singapore has progressed tremendously, says Prof Lescar, who studies the molecular structure of RNA viruses, including coronaviruses, and the ways they infect humans.
"I am amazed by the number of excellent dedicated scientists and superb facilities that are now in place here," he says.
"We should pay tribute to the vision of the leaders who supported this and the great dedication of the staff and managers running facilities such as NCID and the hospitals."
Singapore has, over the past 100 days or so, achieved a number of key scientific milestones.
But the work continues, as scientists move to peel back the remaining layers of unknowns about the virus. And many mysteries still remain, says Prof Lescar.
For instance, even though this virus is in the same family as the one that caused Sars, it is still not known why this one is so much more contagious, he says.
It is also unclear why some Covid-19 patients develop severe disease while others do not.
"The good news is that there is a huge international effort to address these issues, which hopefully will lead to vaccines and cures in the form of specific anti-viral drugs," Prof Lescar says.
Preliminary studies have pointed to possible answers, and some important clues may lie in the structure of the virus.
Under a microscope, the coronavirus - called Sars-CoV-2 - appears spherical. In its centre, encased by an oily membrane, is a single-stranded genetic material called RNA. Protruding from the membrane is a crown of spikes made of protein, or S-proteins, Prof Lescar explains.
One possible explanation for the higher infectivity of the virus at the centre of the current outbreak, he says, is that compared with the virus that caused Sars, the spikes of this virus may have a higher affinity for the ACE-2 receptor on the human cell.
Scientists think this receptor, located on the surface of the human cell, could be used by the coronavirus as an entry route.
These spike proteins are what helps the virus "hijack" human cells, the first step of an infection. The S-proteins of the virus latch on to the receptors on the human cell, much like how pieces of a jigsaw puzzle fit together.
This enables the virus to inject its RNA into the human cell, and use the resources of its host to make new copies of the virus.
Prof Lescar says: "It seems like just a few mutations at the surface of the spike protein of the virus are enough to affect how infectious the virus is and also its pathogenicity - the way it harms an infected person."
Viruses are not static but are prone to mutation. This could change the behaviour of a virus, and also affect the sensitivity of a test kit.
Scientists such as Dr Sebastian Maurer-Stroh, deputy executive director of research at A*Star's Bioinformatics Institute, are keeping an eye out on it in case it does.
The active surveillance of the viral genome is key to ensuring that the diagnostic test kits remain sensitive in detecting the virus in Covid-19 patients, says an A*Star spokesman.
A virus' unique genome serves as a "fingerprint" to distinguish it from other viruses. By comparing the genome of the virus causing Covid-19 with that of other viruses, scientists were able to identify parts of the genetic code that were unique to Sars-CoV-2.
These differences allowed scientists to develop diagnostic tests, such as those in the Fortitude Kit. These tests work by flagging the unique parts of the viral genome in a person's respiratory secretions through a process known as polymerase chain reaction (PCR).
Professor Tan Chorh Chuan, chief health scientist at the Ministry of Health, says new tools - including a new serology test developed by Prof Wang - to combat Covid-19 will soon be unveiled.
A serology test, or antibody test, is different from a PCR test.
PCR tests look for the presence of viral genetic material in a sample, but a serology test detects markers of the human immune system.
Specifically, serology tests flag the presence of antibodies, which are proteins developed by the immune system to fight off bacteria or viruses in the body.
"This can be used to assess if a patient had been recently infected, and will be also very helpful in assessing the extent of community exposure to Covid-19 infections," says Prof Tan.
Associate Professor Hsu Li Yang, programme leader for infectious diseases at the National University of Singapore's (NUS) Saw Swee Hock School of Public Health, says the test will not pick up an infection in someone who has just been infected, because antibodies are produced only between days 10 and 14 of the illness.
Antibody testing is also not foolproof, as some 5 per cent of the people who have been infected with the coronavirus disease do not develop antibodies, he says, adding that serological tests are being evaluated here.
Because there are so many parameters to consider - from the type of drug to the ways the drugs can be combined and in varying doses - it is a task that can sometimes feel like searching for a nail in 10 galaxies, says Professor Dean Ho.
While the presence of antibodies may be indicative that a person has recovered from Covid-19, it is not clear if they protect against the disease for sure.
For instance, there have been reports that South Korea is seeing a growing number of recovered Covid-19 patients who relapsed.
A successful coronavirus vaccine, on the other hand, would confer immunity, and developing this is the subject of research worldwide.
Billionaire Bill Gates, whose Bill and Melinda Gates Foundation is funding seven Covid-19 vaccine candidates, recently said a coronavirus vaccine could be manufactured at scale in just a year.
There are now at least 76 vaccine candidates and, in Singapore, the Duke-NUS Medical School has tied up with Arcturus Therapeutics in the United States to develop one, based on a new way of making a vaccine. Clinical trials are expected to start by August.
In the meantime, groups of scientists are studying how infected patients could be better treated. This includes efforts across the local research ecosystem to look at the use of repurposed drugs and explore various drug combinations that might prove to be an effective cure, says A*Star.
Professor Dean Ho, director of the N.1 Institute for Health and the Institute for Digital Medicine at NUS, is working with a collaborator to leverage artificial intelligence in the search for the best combination of drugs in the best doses to treat Covid-19 patients.
Because there are so many parameters to consider - from the type of drug to the ways the drugs can be combined and in varying doses - it is a task that can sometimes feel like searching for a nail in 10 galaxies, he says.
Enter IDentif.AI (pronounced Identify), a platform that can rapidly optimise drug regimens for infectious diseases.
The platform uses a pool of 12 carefully selected drugs - including the ritonavir and lopinavir combination used to treat HIV patients - to figure out the optimal dosage of drugs that can be used in combination for the treatment of Covid-19 patients.
There are multiple ways that drugs can work, Prof Ho explains.
One, the drug could have a direct effect on the virus. For example, it could stop a virus from replicating in the body. But there may be limits on how high a dose can be administered to a patient, because of factors such as how toxic the drug is, for example.
Two, in a cocktail of medicine taken by a patient, a drug could also help by reducing the side effects caused by another drug in the mix. Or, it could work by reinforcing the positive effects of another drug.
Prof Ho, who is also head of the NUS Department of Biomedical Engineering, says: "Biology is complex and drug interactions can be unpredictable. But AI allows us to interrogate and study huge parameters in a short span of time."
IDentif.AI could soon be used to rank the best drug combinations and dosing for Covid-19 patients, he says.
"And with the results, we will follow up with potential clinical collaborators in Singapore to potentially roll out a drug trial involving an AI-optimised combination of drugs, which may be a world's first."
Singapore's ability to respond rapidly with technology-driven solutions to the Covid-19 pandemic was possible only because of consistent investment in the nation's research, innovation and enterprise ecosystem, says NRF.
"Without the investments we made years ago, we would not have these capabilities today," says the spokesman.
"It is thus important that we continue to invest in building new capabilities today, so that we will also have the capacity to deal with the emergencies of tomorrow."
- For cancer treatment and more, genetic-based precision medicine holds a lot of promise - Connecticut Magazine - May 31st, 2020
- Drug factories: GMOs and gene editing are poised to transform medicine. Here's how. - Genetic Literacy Project - May 31st, 2020
- How to know your risk factors for hypertension and whether high blood pressure is genetic - Insider - INSIDER - May 31st, 2020
- Venture capital found its footing in biotech. Then came the virus. - BioPharma Dive - May 31st, 2020
- Israeli Lab: Drugs For Gaucher Disease May Work Against Coronavirus, Other Viral Infections | Health News - NoCamels - Israeli Innovation News - May 31st, 2020
- Rapid Growth on Genetic Testing Market with COVID-19 Impact Analysis, Top Key Companies like Abbott Laboratories Bio-Rad Laboratories Inc.,... - May 31st, 2020
- insideHPC Special Report: HPC and AI for the Era of Genomics - insideHPC - May 31st, 2020
- More insight into the cytokine storm caused by Covid-19 could lead to a treatment - Health24 - May 31st, 2020
- UCalgary researchers launch 360-degree study of children and COVID-19 - UCalgary News - May 31st, 2020
- 4000 Years of contact, conflict and cultural change had little genetic impact in Near East - University of Birmingham - May 31st, 2020
- Precision Medicine Market Overview By Growing Demands, Trends And Business Opportunities 2020 To 2027 - Cole of Duty - May 31st, 2020
- NOT REAL NEWS: A look at what didn't happen this week - wausaupilotandreview.com - May 31st, 2020
- Precision Medicine Informs Cost-Effective Heart Disease Treatments - HealthITAnalytics.com - May 19th, 2020
- Colonizing Mars may require humanity to tweak its DNA - Space.com - May 19th, 2020
- Complement genes add to sex-based vulnerability in lupus and schizophrenia - Newswise - May 19th, 2020
- 23andMe Is Trying to Crack the Genetic Code Behind the Coronavirus - Motley Fool - May 19th, 2020
- Global Molecular Diagnostics Industry 2019-2029: Genetic Disorders, Cardiovascular Disorders, Infections and Cancer - Yahoo Finance UK - May 19th, 2020
- Prominent Cancer Researcher to Join DRI and Renown Health - GlobeNewswire - May 19th, 2020
- Research Roundup: HIV vaccination, diabetes two-in-one injection, hybrid fish genetics - The Stanford Daily - May 19th, 2020
- Singapore researches discover specific gene linked to Asian Lung Cancer - BSA bureau - May 19th, 2020
- Grant will help scientists break new ground in gene editing - Newswise - May 19th, 2020
- Genomic Medicine Market 2020 | Know the Latest COVID19 Impact Analysis And Strategies of Key Players: Ingersoll Rand, Johnson Controls, Daikin, United... - May 19th, 2020
- Dyne Therapeutics Accelerates Programs in Facioscapulohumeral Muscular Dystrophy (FSHD) with Exclusive Licensing of Technologies to Target Genetic... - May 19th, 2020
- Coronavirus immunity passports could create a world of 'us and them'. But here's why they make sense - Genetic Literacy Project - May 19th, 2020
- New Stem Cell-Based Topical Solution Helps Bald People Regrow Hair - SciTechDaily - May 19th, 2020
- Scientists race to find a cure or vaccine for the coronavirus. Here are the top drugs in development - CNBC - May 19th, 2020
- WHITEHALL ANALYTICA THE AI SUPERSTATE: Part 2 Is COVID-19 Fast-Tracking a Eugenics-Inspired Genomics Programme in the NHS? - Byline Times - May 19th, 2020
- CRISPR And CRISPR-Associated (Cas) Genes Market Size, Share, Trends and Forecast 2026 by Major Players and Business Opportunities Caribou... - May 19th, 2020
- Researchers: Disease affecting kids could be in the genes - Newsday - May 19th, 2020
- From Competition To Sharing: How Her Childrens Rare Disease Led Sharon Terry To Revolutionize Medical Research - Forbes - May 9th, 2020
- Infection rates may have links to cancer - Medical News Today - May 9th, 2020
- Twin peeks: Stanford inherits twin registry, expanding research options - Stanford Medical Center Report - May 9th, 2020
- Management of Fertility and Hormonal Health in Women at Risk for Hereditary Gynecologic Cancers - Endocrinology Advisor - May 9th, 2020
- Individualized mosaics of microbial strains transfer from the maternal to the infant gut - Newswise - May 9th, 2020
- The Falsehoods of the 'Plandemic' Video - FactCheck.org - May 9th, 2020
- Its in your genes Whether Covid lands you in hospital or not depends on your body - ThePrint - May 9th, 2020
- FDA approves Tabrecta, first targeted therapy to treat metastatic NSCLC - The Cancer Letter - May 9th, 2020
- Research into the health of unborn babies receives government funding - UNSW Newsroom - May 9th, 2020
- Genetics and Weight: Is There an Obesity Gene? - LIVESTRONG.COM - May 9th, 2020
- New medical foundation invests in COVID-19 research funding - News - The University of Sydney - May 9th, 2020
- What Do Your Genetics Have to Do With Your Chances of Dying From Coronavirus? - Vanity Fair - May 3rd, 2020
- Scientists Find New Way to Inject Plants With Medicine, And It May Help Save Our Crops - ScienceAlert - May 3rd, 2020
- Sarepta Therapeutics Announces Research Agreement with US Department of Defense to Evaluate Multiple Constructs From its Proprietary RNA Platform as... - May 3rd, 2020
- Evanston hospitals expand to antibody testing - The Daily Northwestern - May 3rd, 2020
- Profits and Pride at Stake, the Race for a Vaccine Intensifies - The New York Times - May 3rd, 2020
- Data On Thousands Of Twins Reveals How Genetics Influences Covid-19 Symptoms - IFLScience - May 3rd, 2020
- The pieces of the puzzle of covid-19s origin are coming to light - The Economist - May 3rd, 2020
- LIST: UW awards $2.2 million to groups, scientists fighting the coronavirus in Wisconsin - WMTV - May 3rd, 2020
- World Laughter Day 2020: Why we must remember that laughter is indeed the best medicine - Hindustan Times - May 3rd, 2020
- When COVID-19 Mutates, What Are the Risks? - MedicineNet - May 3rd, 2020
- Facts that China is trying to suppress about origin of COVID-19 - WION - May 3rd, 2020
- COVID-19: What's RNA research got to do with it? - University of Rochester - May 3rd, 2020
- Welcome to the kingdom of the sick - Salon - May 3rd, 2020
- Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection - CMAJ - May 3rd, 2020
- XBiotech Identifies Super Bloods for the Development of a True Human COVID-19 Therapy - GlobeNewswire - May 3rd, 2020
- On National DNA Day, scientists are trying to take the colonialism out of genetics - Massive Science - April 26th, 2020
- Turning On the 'Off Switch' in Cancer Cells - Michigan Medicine - April 26th, 2020
- Turkey's top scientific body invests TL 2.3 billion on 16 vaccine projects over 5 years | Daily Sabah - Daily Sabah - April 26th, 2020
- Covid-19 will pass. What about the racism it has illuminated? - STAT - April 26th, 2020
- Infection Rate May Indicate a Future Diagnosis of Cancer - Cancer Network - April 26th, 2020
- Misleading coronavirus information falsely attributed to Johns Hopkins - AFP Factcheck - April 26th, 2020
- He signed up for a coronavirus vaccine trial using a method that's never been used in humans. Here's why. - CNN - April 26th, 2020
- New study could lead to therapeutic interventions to treat cocaine addiction - Newswise - April 26th, 2020
- As Cuomo Issues New Executive Order, Weill Cornell Medicine Ramps Up COVID-19 Testing - Cornell University The Cornell Daily Sun - April 26th, 2020
- Another Step Towards Earlier Detection of Pancreatic Cancer - MedPage Today - April 26th, 2020
- UW president, biochemistry chair and mathematics professor named to American Academy of Arts and Sciences - UW News - April 26th, 2020
- Mustang Bio Receives Advanced Therapy Medicinal Product Classification from European Medicines Agency for MB-107 Lentiviral Gene Therapy for X-Linked... - April 26th, 2020
- Childhood Psychopathology Linked to Higher Levels of Genetic Vulnerability of Adult Depression - Clinical OMICs News - April 26th, 2020
- Gdask scientist makes crucial headway in understanding killer virus by isolating COVID-19 DNA from infected patient - The First News - April 26th, 2020
- Ethiopia's Ministry of Health Holds Webinar With Diaspora on COVID-19 Response at Tadias Magazine - Tadias Magazine - April 26th, 2020
- Immunity and our DNA: Why women are the stronger sex - The Age - April 26th, 2020
- Nobel laureate Luc Montagnier inaccurately claims that the novel coronavirus is man-made and contains genetic material from HIV - Health Feedback - April 26th, 2020
- Concert Genetics Presents Real-World Data on Utilization of NGS-Based Diagnostic Tests in NCCN 2020 Abstract - news-herald.net - April 2nd, 2020
- What scientists know about COVID-19 -- and what they don't - PBS NewsHour - April 2nd, 2020
- UVA Finds Way to Improve Cancer Outcomes by Examining Patients' Genes - University of Virginia - April 2nd, 2020
- Brown Alpert Medical School Autism Expert on Latest Advances in Research and Testing - GoLocalProv - April 2nd, 2020
- Coronavirus testing is ramping up. Here are the new tests and how they work. - Livescience.com - April 2nd, 2020
- Muscular Dystrophy Association Announces Formation of Strategic Medical Advisory Team of Experts in Neuromuscular Care and Research - PRNewswire - April 2nd, 2020
- Modalis Obtains Access to Foundational CRISPR IP - BioSpace - April 2nd, 2020
- Group behind NYC COVID-19 tent hospital is forcing medical workers to abide by anti-gay statement of faith - Metro Weekly - April 2nd, 2020